Biohybrid systems allow for new applications in food technology, molecular biology, medical diagnostics, and pharmaceutical industry
Cells, biological circuits, and individual biomolecules organize themselves and interact with the environment. Use of these capabilities in flexible and economically efficient biotechnological production systems is in the focus of the “Molecular Interaction Engineering” (MIE) project. It is the objective to develop printed biological circuits and catalysts for biologico-technical hybrid systems. MIE will be funded with about EUR 3.5 million by the BMBF.
The capabilities of biological systems are based on specific interactions of molecular components. Due to their molecular fitting accuracy, for instance, enzymes allow for certain chemical reactions only. Some proteins bind via specific molecular interfaces to the DNA or other proteins and control processes in complex organisms. Sensors respond to defined molecular signals from the environment. The MIE project focuses on interactions of molecules, technical interfaces, and surrounding solvents.
“Transfer of complex biological mechanisms to printable systems may result in innovative biotechnologies that might be the basis of a number of industrial applications,” Professor Jürgen Hubbuch, project coordinator at KIT, explains. However, conventional, continuous evolution of biological molecules reaches its limits. The key to innovative developments is the specific, adjusted construction of the interaction of complex biomolecules and fusion of these units with technical interfaces. This requires close cooperation of biology, engineering, chemistry, and physics.
The “Molecular Interaction Engineering” (MIE) project combines methods of biotechnology, structural biology, materials sciences, process engineering, and computer simulation. Work is aimed at developing innovative, flexible, and economically efficient biotechnological production systems for molecules. These might then be used in biohybrid systems integrating biological and electronic components. Biohybrid systems allow for new applications in food technology, molecular biology, medical diagnostics, and pharmaceutical industry.
The Latest on: Printable Biotechnology
- In biotech and in life, it’s a process of accepting — and understanding — mortality on December 16, 2018 at 9:00 pm
And as a worker in the biotech industry, I also know that there is another road: We need not seek to cure death (and truth be told, we cannot). Curing lives for all humanity — and coming to an underst... […]
- Can Cambridge become the world's leading biotech cluster? on December 10, 2018 at 9:35 pm
Create a free account with Management Today to access up to four articles a month. For full access, including special print issues and event discounts, see our subscription packages. […]
- Moderna Declines in Market Debut -- WSJ on December 8, 2018 at 7:28 am
This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street ... as investors sold the risky biotechnology fi... […]
- CELLINK partners with Prellis Biologics to advance $1.2 million high-precision Holograph-X Bioprinter on December 6, 2018 at 4:17 am
CELLINK, a Swedish manufacturer of 3D bioprinters and bioprinting materials, and Prellis Biologics a San Francisco biotechnology ... is used to 3D print fine capillaries, that deliver nutrients ... […]
- City offers $10M for biotech startups to expand on December 3, 2018 at 9:44 am
"This is an opportunity to help biotech companies solve for space on a near-term basis." As a loyal print subscriber you are eligible for FREE full digital access to the best business coverage in New ... […]
via Google News and Bing News